참고문헌
- Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM (1999). The accuracy of urinary cytology in daily practice. Cancer, 87, 118-28. https://doi.org/10.1002/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO;2-N
- Bhatia A, Dey P, Kakkar N, et al (2006). Malignant atypical cell in urine cytology: a diagnostic dilemma. Cytojournal, 3, 28. https://doi.org/10.1186/1742-6413-3-28
- Brimo F, Vollmer RT, Case B, et al (2009). Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol, 132, 785-93. https://doi.org/10.1309/AJCPPRZLG9KT9AXL
- Cibas ES, Ducatman BS (2009). In "Cytopathology Diagnostic Principles and Clinical Correlates", Saunders Elsevier, Philadelphia, PA.
- Deshpande V, McKee GT (2005). Analysis of atypical urine cytology in a tertiary care center. Cancer, 105, 468-75. https://doi.org/10.1002/cncr.21317
- Kanagawa Urological Research Group (2012). A 2-week maintenance regimen of intravesical instillation of bacillus Calmette-Guerin is safe, adherent and effective in patients with non-muscle-invasive bladder cancer: a prospective, multicenter phase II clinical trial. Jpn J Clin Oncol, 42, 813-9. https://doi.org/10.1093/jjco/hys097
- Kapur U, Venkataraman G, Wojcik EM (2008). Diagnostic significance of ‘atypia' in instrumented versus voided urine specimens. Cancer, 114, 270-4. https://doi.org/10.1002/cncr.23656
- Mokhtar GA, Al-Dousari M, Al-Ghamedi D (2010). Diagnostic significance of atypical category in the voided urine samples: A retrospective study in a tertiary care center. Urol Ann, 2, 100-6. https://doi.org/10.4103/0974-7796.68857
- Muus Ubago J, Mehta V, Wojcik EM, Barkan GA (2013). Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol, 121, 387-91. https://doi.org/10.1002/cncy.21278
- Nabi G, Greene D, O'Donnell MO (2004). Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up? J Clin Pathol, 57, 365-8. https://doi.org/10.1136/jcp.2003.009696
- Powsner SM, Costa J, Homer RJ (2000). Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med, 124, 1040-6.
- Raab SS, Grzybicki DM, Vrbin CM, Geisinger KR (2007). Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol, 127, 946-53. https://doi.org/10.1309/XUVXFXMFPL7TELCE
- Raitanen MP, Aine RA, Kaasinen ES, et al (2002). Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? Scand J Urol Nephrol, 36, 213-7. https://doi.org/10.1080/003655902320131901
- Sternberg I, Rona R, Olsfanger S, et al (2011). The clinical significance of class III (suspicious) urine cytology. Cytopathology, 22, 329-33. https://doi.org/10.1111/j.1365-2303.2010.00827.x
- Sullivan PS, Chan JB, Levin MR, Rao J (2010). Urine cytology and adjunct markers for detection and surveillance of bladder cancer. Am J Transl Res, 2, 412-40.
- Turco P, Houssami N, Bulgaresi P, et al (2011). Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry. Acta Cytol, 55, 193-6. https://doi.org/10.1159/000320861
- Whisnant RE, Bastacky SI, Ohori NP (2003). Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Diagn Cytopathol, 28, 186-90. https://doi.org/10.1002/dc.10263
피인용 문헌
- Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3543
- High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin pp.1934662X, 2017, https://doi.org/10.1002/cncy.21947